Nonclinical Efficacy And Toxicity And Selection Of A Safe Clinical Starting Dose For An Nmt Inhibitor In Development For Hematological MalignanciesMichael J. Weickert,John Dillberger,Caren Brown, Francis Phaneuf,John R. Mackey,Randeep Sangha,Luc G. BerthiaumeBLOOD(2020)引用 0|浏览14暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要